Which countries run stem-cell trials for Erectile Dysfunction?
Sites appear in 16 countries, led by United States at about 28% of all country mentions (2026-08-29).
Country distribution
| Country | Studies with a site there |
|---|---|
| United States | 7 |
| South Korea | 4 |
| China | 4 |
| Denmark | 2 |
| Jordan | 2 |
| Indonesia | 2 |
| Kazakhstan | 1 |
| United Arab Emirates | 1 |
| Lebanon | 1 |
| Saudi Arabia | 1 |
A study with sites in several countries is counted once per country, taken from the location block of each registry record.
What the map means for Erectile Dysfunction
Registered work is scattered across urology departments in a handful of countries, while the commercial market is dominated by clinics selling packages that bundle injections with shockwave therapy. The absence of a country from the trial map says nothing about how many clinics there advertise the service.
Where recruitment is actually open
| Country | Open studies with a site there |
|---|---|
| United States | 2 |
| United Arab Emirates | 1 |
| Turkey (Türkiye) | 1 |
| South Korea | 1 |
| Antigua and Barbuda | 1 |
What travelling for a trial actually involves
If a site is abroad, the practical questions are who provides follow-up at home, what happens if an adverse event occurs after you fly back, and whether the protocol permits remote assessment at all. Most do not.
Multi-country studies, named
Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.
No sampled study for this condition lists sites in more than one country, so the research base here is made of single-centre work rather than multinational collaboration.
Why trial geography is not a shortlist
Trial locations follow regulation, funding and sponsor headquarters, not clinical quality. Countries with clear conditional pathways for advanced therapies and large public research budgets register more studies. A country appearing here also says nothing about whether commercial clinics there operate under the same oversight as the registered trials.
Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.
When these studies started
Registrations by start year since 2020: 2020 (3), 2021 (1), 2022 (1), 2024 (4), 2025 (3), 2026 (2). Activity for this condition spans 2010 to 2026, which shows whether interest is growing, flat or past its peak.
Frequently asked
Which countries run stem-cell trials for Erectile Dysfunction?
Sites are registered in 16 countries; the largest is United States (~28% of country mentions, 2026-08-29).
Does a country with many trials mean better treatment there?
No — trial counts describe where research is permitted and paid for. Care quality is decided at the level of the individual provider and product.
Are trial sites and commercial clinics the same thing?
They are generally distinct. Proximity in a city or even a shared address does not make a commercial clinic part of a registered protocol — ask for the identifier.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Erectile Dysfunction: cell-therapy evidence and registered trials
- How much does stem cell therapy for Erectile Dysfunction cost? (2026)
- Erectile Dysfunction stem cell therapy — your questions answered (2026)
- Erectile Dysfunction: cell-therapy evidence by therapy class
- MSC vs PRP for Erectile Dysfunction: what the registries show